🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to compare the safety and preliminary efficacy...
Status
Completed
Location
Chiba University Hospital
Start Date
2019-05-23
Trial ID
NCT03955315
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
This study is designed to investigate the efficacy, safety and tolerability...
Status
Unknown
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02395549
Treatments Being Tested
Demonstrate the safety and efficacy of NB-001 in subjects with recurrent he...
Status
Completed
Location
Radiant Research, Inc
Start Date
2011-04
Trial ID
NCT01321359
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This was a Phase III, Efficacy and Safety Study of Oleogel-S10 in Participa...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2017-03-29
Trial ID
NCT03068780
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pimecroli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-12
Trial ID
NCT00510003
Treatments Being Tested